Article actualité
Plus d'articles...
- Zika/Neurological Syndromes Emergency Committee
- Final Programme of the International Conference on Bio-based Materials
- WHO statement on the second meeting of the International Health Regulations (2005) (IHR(2005)) Emergency Committee on Zika virus and observed increase in neurological disorders and neonatal malformations
- Actinium Pharmaceuticals Announces Filing of Provisional Patent Application Related to Commercial Scale Labeling and Processes for Iomab-B